Research never stops


Jul 24, 2015

Evotec enters innovative research initiative with Gladstone Institutes and Dolby Family Ventures in Alzheimer's Disease

San Francisco, USA; Hamburg, Germany - 24 July 2015: Evotec AG today announced that it has become part of a research initiative between a newly established for-profit company of the Gladstone Institutes called Cure Network Ventures, Inc. and Dolby Family Ventures.

- read more
Jun 30, 2015

Evotec's partner Roche provides initial update from Phase IIb trial in Alzheimer's disease

Hamburg, Germany - 30 June 2015: Evotec AG was updated today by its partner Roche on the initial results of the Phase IIb trial with Sembragiline, a MAO-B inhibitor for the treatment of Alzheimer's disease.

- read more
Jun 09, 2015

Resolutions of the Annual General Meeting of Evotec AG

Hamburg - 09 June 2015: Evotec AG today announced that its shareholders approved all proposals the Company's Management put to vote at the Company's Annual General Meeting, which took place today, with the required majority.

- read more
May 12, 2015

Evotec AG reports results of first quarter 2015

Apr 29, 2015

Facio partners with Evotec and initiates FSHD drug discovery programme

Mar 26, 2015

Asahi Kasei Pharma selects Evotec as its partner for ion channel drug discovery

Mar 24, 2015

Evotec FY 2014: Strong performance in EVT Execute and acceleration of EVT Innovate

Hamburg, Germany - 24 March 2015: Evotec AG today announced its financial results for the fiscal year ended 31 December 2014.

- read more
Mar 20, 2015

Evotec and Sanofi sign definitive agreement for major multi-component strategic alliance

Mar 13, 2015

Second Genome and Evotec to collaborate in microbiome discovery and development

Hamburg, Germany - 13 March 2015: Evotec AG and Second Genome, Inc. today announced a collaboration in small molecule-based discovery and development activities for the treatment of microbiome-mediated diseases.

- read more
Feb 13, 2015

Evotec’s approach to phenotypic screening

On the 11 June 2015 at 3 pm GMT (10 am EDT; 4 pm CET) in a free webinar, York Rudhard, Principal Scientist, and Mike Bodkin, VP Research Informatics at Evotec will provide insights into Evotec’s approach to phenotypic screening

To register and join the discussion, please click here

- read more
Jan 19, 2015

Evotec and C4XD enter collaboration to identify pre-clinical development candidates for stress-related addictive disorder programme

Jan 15, 2015

Evotec achieves further milestones in TargetAD collaboration with Janssen

Jan 07, 2015

Evotec and Padlock Therapeutics announce initial success and extension of long-term collaboration